BioNTech SE BNTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:51 PM EDT
195.60quote price arrow down-2.42 (-1.22%)
Volume
18,235
Close
198.02quote price arrow down-4.33 (-2.14%)
Volume
4,382,132
52 week range
45.08 - 213.15

...

Loading . . .
  • Open186.61
  • Day High202.50
  • Day Low185.00
  • Prev Close202.35
  • 52 Week High213.15
  • 52 Week High Date05/04/21
  • 52 Week Low45.08
  • 52 Week Low Date05/14/20

Key Stats

  • Market Cap47.826B
  • Shares Out241.52M
  • 10 Day Average Volume5.78M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change142.91

KEY STATS

  • Open186.61
  • Day High202.50
  • Day Low185.00
  • Prev Close202.35
  • 52 Week High213.15
  • 52 Week High Date05/04/21
  • 52 Week Low45.08
  • 52 Week Low Date05/14/20
  • Market Cap47.826B
  • Shares Out241.52M
  • 10 Day Average Volume5.78M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change142.91

RATIOS/PROFITABILITY

  • EPS (TTM)5.04
  • P/E (TTM)39.29
  • Fwd P/E (NTM)7.64
  • EBITDA (MRQ)2.04B
  • ROE (MRQ)80.65%
  • Revenue (MRQ)3.036B
  • Gross Margin (MRQ)88.55%
  • Net Margin (MRQ)47.81%
  • Debt To Equity (MRQ)26.07%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO4:4004:40
Oppenheimer health care analyst on whether vaccine makers should lose sleep over patent waivers

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
381.51+1.05+0.28%
SGEN
Seagen Inc
139.07+3.14+2.31%
MRNA
Moderna Inc
158.99+0.44+0.28%
GMAB
Genmab A/S
36.73-0.51-1.37%
INCY
Incyte Corp
80.64-0.75-0.92%